CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 6, Pages e0130519
Publisher
Public Library of Science (PLoS)
Online
2015-06-19
DOI
10.1371/journal.pone.0130519
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas
- (2014) Karl Holmberg Olausson et al. PLoS One
- Human Glioma–Initiating Cells Show a Distinct Immature Phenotype Resembling but Not Identical to NG2 Glia
- (2013) Alonso Barrantes-Freer et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy
- (2013) Kaoru Tamura et al. JOURNAL OF NEUROSURGERY
- Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma
- (2013) Bi-Sen Ding et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
- (2013) Marju Kase et al. Radiology and Oncology
- CD133 Is Essential for Glioblastoma Stem Cell Maintenance
- (2013) Paola Brescia et al. STEM CELLS
- Thickness profiling of formaldehyde-fixed cells by transmission-through-dye microscopy
- (2012) Mariana Pelts et al. BIOTECHNIQUES
- Characteristic Features of Stem Cells in Glioblastomas: From Cellular Biology to Genetics
- (2012) Mark J. Knights et al. BRAIN PATHOLOGY
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?
- (2012) Paola Brescia et al. Journal of Oncology
- Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway
- (2011) Nicola Bauer et al. EMBO Molecular Medicine
- CD133 ProteinN-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope
- (2011) Anthony B. Mak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas
- (2011) Kyung-Jung Kim et al. NEUROPATHOLOGY
- A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
- (2011) X. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD133 and membrane microdomains: Old facets for future hypotheses
- (2011) Christine A Fargeas WORLD JOURNAL OF GASTROENTEROLOGY
- Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions
- (2011) J D Lathia et al. Cell Death & Disease
- A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
- (2010) Ruihuan Chen et al. CANCER CELL
- The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
- (2010) K. Kemper et al. CANCER RESEARCH
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation
- (2010) Denis Corbeil et al. FEBS LETTERS
- Insight into the complex regulation of CD133 in glioma
- (2010) Benito Campos et al. INTERNATIONAL JOURNAL OF CANCER
- Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks
- (2010) Kouichi Tabu et al. Molecular Cancer
- A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
- (2009) Aurélie Tchoghandjian et al. BRAIN PATHOLOGY
- How powerful is CD133 as a cancer stem cell marker in brain tumors?
- (2009) Jin-Xiang Cheng et al. CANCER TREATMENT REVIEWS
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- Limits of CD133 as a marker of glioma self-renewing cells
- (2009) Virginie Clément et al. INTERNATIONAL JOURNAL OF CANCER
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
- (2009) Yirui Sun et al. PLoS One
- Cell Cycle-Dependent Variation of a CD133 Epitope in Human Embryonic Stem Cell, Colon Cancer, and Melanoma Cell Lines
- (2008) M. Jaksch et al. CANCER RESEARCH
- Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
- (2008) J. M. Yi et al. CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma
- (2008) Anastasia Murat et al. JOURNAL OF CLINICAL ONCOLOGY
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
- (2008) Scott Bidlingmaier et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
- (2008) Kyeung Min Joo et al. LABORATORY INVESTIGATION
- CD133 Is a Marker of Bioenergetic Stress in Human Glioma
- (2008) Corinne E. Griguer et al. PLoS One
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now